Shattuck Labs (STTK) Other Non-Current Assets (2019 - 2026)
Shattuck Labs (STTK) reported Other Non-Current Assets of $2.0 million for Q1 2026, up 6.73% year-over-year from $1.9 million in Q1 2025, and up 40.22% quarter-over-quarter from $1.4 million in Q4 2025.
Shattuck Labs (STTK) Other Non-Current Assets (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 8 years of Other Non-Current Assets data on file, last reported at $2.0 million in Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $2.0 million, up 6.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.0 million (up 6.73% YoY), and the FY2025 annual result was $1.4 million, down 28.93% from the prior year.
- Other Non-Current Assets advanced to $2.0 million in Q1 2026 per STTK's latest filing, from $1.4 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $3.2 million in Q1 2022 and troughed at $1.4 million in Q4 2025.
- A 5-year average of $2.5 million and a median of $2.5 million in 2023 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets surged 1066.67% in 2022, then fell 28.93% in 2025.
- A 5-year view of Other Non-Current Assets shows it stood at $3.1 million in 2022, then fell by 17.24% to $2.5 million in 2023, then slipped by 20.39% to $2.0 million in 2024, then fell by 28.93% to $1.4 million in 2025, then soared by 40.22% to $2.0 million in 2026.
- Business Quant data shows STTK's Other Non-Current Assets at $2.0 million in Q1 2026, $1.4 million in Q4 2025, and $2.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Shattuck Labs | 190.32 Mn | 190.32 Mn | - | 2.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.02 Mn |
| Dec 31, 2025 | 1.44 Mn |
| Sep 30, 2025 | 2.56 Mn |
| Jun 30, 2025 | 1.75 Mn |
| Mar 31, 2025 | 1.89 Mn |
| Dec 31, 2024 | 2.02 Mn |
| Sep 30, 2024 | 2.15 Mn |
| Jun 30, 2024 | 2.29 Mn |
| Mar 31, 2024 | 2.43 Mn |
| Dec 31, 2023 | 2.54 Mn |
| Sep 30, 2023 | 2.67 Mn |
| Jun 30, 2023 | 2.81 Mn |
| Mar 31, 2023 | 2.95 Mn |
| Dec 31, 2022 | 3.07 Mn |
| Sep 30, 2022 | 3.19 Mn |
| Jun 30, 2022 | 3.16 Mn |
| Mar 31, 2022 | 3.23 Mn |
| Dec 31, 2021 | 381,000.00 |
| Sep 30, 2021 | 273,000.00 |
| Jun 30, 2021 | 331,000.00 |